Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management

Phil Raess, Marilyn Baird-Howell, Rajesh Aggarwal, Noel N. Williams, Emma E. Furth

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background Laparoscopic vertical sleeve gastrectomy is used with increasing frequency as a therapeutic option for morbid obesity. Before the procedure, patients undergo a rigorous preoperative evaluation including double contrast upper gastrointestinal radiographic series at our institution. Patients undergoing sleeve gastrectomy are presumed to have no significant gastric pathology. Objectives: To investigate the prevalence of histopathologic findings requiring clinical follow-up in sleeve gastrectomy specimens. Setting: University Hospital, United States. Methods Retrospective review was conducted of all primary vertical sleeve gastrectomy specimens performed for morbid obesity at our institution from July 2008 until August 2012 (N = 248). Results Unanticipated findings warranting clinical follow-up were identified in 8.4% of cases and included cases of H. pylori gastritis, autoimmune gastritis with microcarcinoid formation, necrotizing vasculitis, and intestinal metaplasia. H. pylori was identified in 5.2% of all cases and in 33.3% of cases of gastritis. Neoplasms were identified at laparoscopy in 2 additional cases (0.8%). Conclusions Surgeons and pathologists should be aware of the high prevalence of diagnoses requiring clinical follow-up in vertical sleeve gastrectomy specimens.

Original languageEnglish (US)
Pages (from-to)1020-1023
Number of pages4
JournalSurgery for Obesity and Related Diseases
Volume11
Issue number5
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

Gastrectomy
Gastritis
Morbid Obesity
Pylorus
Metaplasia
Vasculitis
Laparoscopy
Stomach
Pathology
Neoplasms
Therapeutics

Keywords

  • Pathologic findings
  • Sleeve gastrectomy
  • Unexpected follow-up

ASJC Scopus subject areas

  • Surgery

Cite this

Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management. / Raess, Phil; Baird-Howell, Marilyn; Aggarwal, Rajesh; Williams, Noel N.; Furth, Emma E.

In: Surgery for Obesity and Related Diseases, Vol. 11, No. 5, 01.09.2015, p. 1020-1023.

Research output: Contribution to journalArticle

Raess, Phil ; Baird-Howell, Marilyn ; Aggarwal, Rajesh ; Williams, Noel N. ; Furth, Emma E. / Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management. In: Surgery for Obesity and Related Diseases. 2015 ; Vol. 11, No. 5. pp. 1020-1023.
@article{61c61037e28b49bda974f1ea95efa01a,
title = "Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management",
abstract = "Background Laparoscopic vertical sleeve gastrectomy is used with increasing frequency as a therapeutic option for morbid obesity. Before the procedure, patients undergo a rigorous preoperative evaluation including double contrast upper gastrointestinal radiographic series at our institution. Patients undergoing sleeve gastrectomy are presumed to have no significant gastric pathology. Objectives: To investigate the prevalence of histopathologic findings requiring clinical follow-up in sleeve gastrectomy specimens. Setting: University Hospital, United States. Methods Retrospective review was conducted of all primary vertical sleeve gastrectomy specimens performed for morbid obesity at our institution from July 2008 until August 2012 (N = 248). Results Unanticipated findings warranting clinical follow-up were identified in 8.4{\%} of cases and included cases of H. pylori gastritis, autoimmune gastritis with microcarcinoid formation, necrotizing vasculitis, and intestinal metaplasia. H. pylori was identified in 5.2{\%} of all cases and in 33.3{\%} of cases of gastritis. Neoplasms were identified at laparoscopy in 2 additional cases (0.8{\%}). Conclusions Surgeons and pathologists should be aware of the high prevalence of diagnoses requiring clinical follow-up in vertical sleeve gastrectomy specimens.",
keywords = "Pathologic findings, Sleeve gastrectomy, Unexpected follow-up",
author = "Phil Raess and Marilyn Baird-Howell and Rajesh Aggarwal and Williams, {Noel N.} and Furth, {Emma E.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.soard.2015.01.002",
language = "English (US)",
volume = "11",
pages = "1020--1023",
journal = "Surgery for Obesity and Related Diseases",
issn = "1550-7289",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management

AU - Raess, Phil

AU - Baird-Howell, Marilyn

AU - Aggarwal, Rajesh

AU - Williams, Noel N.

AU - Furth, Emma E.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background Laparoscopic vertical sleeve gastrectomy is used with increasing frequency as a therapeutic option for morbid obesity. Before the procedure, patients undergo a rigorous preoperative evaluation including double contrast upper gastrointestinal radiographic series at our institution. Patients undergoing sleeve gastrectomy are presumed to have no significant gastric pathology. Objectives: To investigate the prevalence of histopathologic findings requiring clinical follow-up in sleeve gastrectomy specimens. Setting: University Hospital, United States. Methods Retrospective review was conducted of all primary vertical sleeve gastrectomy specimens performed for morbid obesity at our institution from July 2008 until August 2012 (N = 248). Results Unanticipated findings warranting clinical follow-up were identified in 8.4% of cases and included cases of H. pylori gastritis, autoimmune gastritis with microcarcinoid formation, necrotizing vasculitis, and intestinal metaplasia. H. pylori was identified in 5.2% of all cases and in 33.3% of cases of gastritis. Neoplasms were identified at laparoscopy in 2 additional cases (0.8%). Conclusions Surgeons and pathologists should be aware of the high prevalence of diagnoses requiring clinical follow-up in vertical sleeve gastrectomy specimens.

AB - Background Laparoscopic vertical sleeve gastrectomy is used with increasing frequency as a therapeutic option for morbid obesity. Before the procedure, patients undergo a rigorous preoperative evaluation including double contrast upper gastrointestinal radiographic series at our institution. Patients undergoing sleeve gastrectomy are presumed to have no significant gastric pathology. Objectives: To investigate the prevalence of histopathologic findings requiring clinical follow-up in sleeve gastrectomy specimens. Setting: University Hospital, United States. Methods Retrospective review was conducted of all primary vertical sleeve gastrectomy specimens performed for morbid obesity at our institution from July 2008 until August 2012 (N = 248). Results Unanticipated findings warranting clinical follow-up were identified in 8.4% of cases and included cases of H. pylori gastritis, autoimmune gastritis with microcarcinoid formation, necrotizing vasculitis, and intestinal metaplasia. H. pylori was identified in 5.2% of all cases and in 33.3% of cases of gastritis. Neoplasms were identified at laparoscopy in 2 additional cases (0.8%). Conclusions Surgeons and pathologists should be aware of the high prevalence of diagnoses requiring clinical follow-up in vertical sleeve gastrectomy specimens.

KW - Pathologic findings

KW - Sleeve gastrectomy

KW - Unexpected follow-up

UR - http://www.scopus.com/inward/record.url?scp=84952870683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952870683&partnerID=8YFLogxK

U2 - 10.1016/j.soard.2015.01.002

DO - 10.1016/j.soard.2015.01.002

M3 - Article

VL - 11

SP - 1020

EP - 1023

JO - Surgery for Obesity and Related Diseases

JF - Surgery for Obesity and Related Diseases

SN - 1550-7289

IS - 5

ER -